General Information of Drug (ID: DMTZC5G)

Drug Name
Bezlotoxumab Drug Info
Synonyms CDB1; Clostridium difficile toxin B monoclonal antibody; MBL-CDB1; MDX-1388; MK 6072; Zinplava
Indication
Disease Entry ICD 11 Status REF
C. difficile infection 1A04 Approved [1]
Cross-matching ID
TTD Drug ID
DMTZC5G

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
MK-3415A DMGNHC2 Clostridium infection 1A04 Phase 3 [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Clostridium difficile Toxin B (CD toxB) TTQH65V TOXB_CLODI Modulator [1]

References

1 2016 FDA drug approvals. Nat Rev Drug Discov. 2017 Feb 2;16(2):73-76.
2 ClinicalTrials.gov (NCT01513239) A Study of MK-6072 and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-002). U.S. National Institutes of Health.